11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.
about
11 C-PE2I and 18 F-Dopa PET for assessing progression rate in Parkinson's: A longitudinal study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
11 C-PE2I and 18 F-Dopa PET fo ...... inson's: A longitudinal study.
@en
11 C-PE2I and 18 F-Dopa PET fo ...... inson's: A longitudinal study.
@nl
type
label
11 C-PE2I and 18 F-Dopa PET fo ...... inson's: A longitudinal study.
@en
11 C-PE2I and 18 F-Dopa PET fo ...... inson's: A longitudinal study.
@nl
prefLabel
11 C-PE2I and 18 F-Dopa PET fo ...... inson's: A longitudinal study.
@en
11 C-PE2I and 18 F-Dopa PET fo ...... inson's: A longitudinal study.
@nl
P2093
P2860
P50
P356
P1433
P1476
11 C-PE2I and 18 F-Dopa PET fo ...... kinson's: A longitudinal study
@en
P2093
Andreas A Roussakis
Clare Loane
Gesine Paul
Håkan Widner
Marios Politis
Natalie Valle-Guzman
Paola Piccini
Tom Foltynie
P2860
P304
P356
10.1002/MDS.27183
P407
P577
2017-10-30T00:00:00Z